Press Releases

Date	Title
09-19-2023	Kura Oncology to Participate in Cantor Global Healthcare Conference 2023
08-14-2023	Kura Oncology Appoints Brian Powl as Chief Commercial Officer
08-03-2023	Kura Oncology Reports Second Quarter 2023 Financial Results
07-27-2023	Kura Oncology to Report Second Quarter 2023 Financial Results
06-14-2023	Kura Oncology Announces Pricing of $100 Million Public Offering of Common Stock and Pre-Funded Warrants
06-13-2023	Kura Oncology Announces Commencement of Public Offering of Common Stock and Pre-Funded Warrants
06-11-2023	Kura Oncology Presents Late-Breaking Clinical Data for Menin Inhibitor Ziftomenib at 2023 European Hematology Association (EHA) Congress
05-30-2023	Kura Oncology Announces Late-Breaking Abstract Accepted for Oral Presentation at the 2023 European Hematology Association (EHA) Congress
05-23-2023	Kura Oncology to Participate in Two Upcoming Investor Conferences
05-10-2023	Kura Oncology Reports First Quarter 2023 Financial Results

Kura Oncology, Inc.
12730 High Bluff Drive, Suite 400
San Diego, CA 92130
(858) 500-8800

Kura Oncology, Inc.
2 Seaport Lane, Suite 8A
Boston, MA 02210
(617) 588-3755

Kura Oncology, Inc.
5510 Morehouse Drive, Suite 110
San Diego, California 92121

Keyword Search